Pai‐Yu Cheng
Papers
1
Total Citations
4
H-Index
1
About
Pai‐Yu Cheng is a leading urologic oncologist whose research focuses on upper tract urothelial carcinoma (UTUC), a malignancy with notably high prevalence in Taiwan. His major contributions center on optimizing surgical management, particularly through the evaluation of segmental ureterectomy (SU) outcomes in endemic regions. In his landmark 2024 study, "Segmental ureterectomy outcome of upper tract urothelial carcinoma in a high endemic area: A Taiwan nationwide collaborative study," Cheng provided critical evidence supporting SU as a viable, nephron-sparing alternative for selected mid- and distal ureteral tumors, aligning with National Comprehensive Cancer Network guidelines. This work, already cited 4 times, addresses a significant gap in treatment outcome analysis specific to endemic areas. Cheng’s research has direct clinical impact, offering tailored surgical strategies that balance oncologic control with renal function preservation. His collaborative nationwide approach underscores his commitment to improving UTUC management through evidence-based, region-specific insights, making him a key figure in advancing urologic oncology in high-incidence populations.
Research Focus
Key Achievements
Top Papers
- 1